Novo Nordisk A/S buy bullbear
Start price
08.08.22
/
50%
€100.76
Target price
08.08.23
€120.00
Performance (%)
69.31%
End price
09.08.23
€170.60
Summary
This prediction ended on 09.08.23 with a price of €170.60. The BUY prediction by bullbear for Novo Nordisk A/S saw massive gains of 69.31%. Dividends of €1.18 are taken into consideration when calculating the performance. bullbear has 50% into this predictionNovo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S | - | - | - |
| iShares Core DAX® | 0.160% | -1.640% | 12.016% |
| iShares Nasdaq 100 | -3.020% | -4.715% | 37.102% |
| iShares Nikkei 225® | -2.519% | -7.621% | 18.066% |
| iShares S&P 500 | -1.377% | -2.809% | 26.536% |
Comments by bullbear for this prediction
In the thread Novo Nordisk A/S diskutieren
Interesting pharma company with good fundamentals, they also just increased their projections for the year.
In the thread Trading Novo Nordisk A/S
Die von bullbear gewählte maximale Laufzeit wurde überschritten